Cargando…
The role of soluble CD80 in patients with soft tissue tumors
BACKGROUND: Immune checkpoint protein (ICP), which is a central factor group of the immune system, has been reported to have a correlation between the degree of its expression and the prognosis of patients with malignant tumors, and many inhibitors have appeared as therapeutic targets. On the other...
Autores principales: | Matsuyama, Yumi, Asanuma, Kunihiro, Yoshida, Keisuke, Hagi, Tomohito, Iino, Takahiro, Nakamura, Tomoki, Sudo, Akihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446575/ https://www.ncbi.nlm.nih.gov/pubmed/36064421 http://dx.doi.org/10.1186/s13018-022-03283-2 |
Ejemplares similares
-
Radiodynamic therapy with acridine orange local administration as a new treatment option for primary and secondary bone tumours
por: Matsuyama, Yumi, et al.
Publicado: (2022) -
Significance of coagulation and fibrinolysis markers for benign and malignant soft tissue tumors
por: Asanuma, Kunihiro, et al.
Publicado: (2021) -
Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma?
por: Asanuma, Kunihiro, et al.
Publicado: (2022) -
The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas
por: Hagi, Tomohito, et al.
Publicado: (2017) -
Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas
por: Nakamura, Koichi, et al.
Publicado: (2020)